cbdMD Inc. (YCBD)
Company Description
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products.
The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals.
Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids.
It also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name.
The company distributes its products through its e-commerce Website, third-party e-commerce sites, wholesalers, and various brick and mortar retailers in the United States.
It has a research partnership with the University of Mississippi to identify novel cannabinoids.
The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was incorporated in 2015 and is headquartered in Charlotte, North Carolina.
| Country | United States |
| IPO Date | Nov 17, 2017 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 52 |
| CEO | T. Ronan Kennedy |
Contact Details
Address: 8845 Red Oak Boulevard Charlotte, North Carolina United States | |
| Website | https://www.cbdmd.com |
Stock Details
| Ticker Symbol | YCBD |
| Exchange | AMEX |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| CIK Code | 0001644903 |
| CUSIP Number | 12482W101 |
| ISIN Number | US12482W3097 |
| Employer ID | 47-3414576 |
| SIC Code | 2844 |
Key Executives
| Name | Position |
|---|---|
| T. Ronan Kennedy | Interim Chief Executive Officer, Chief Financial Officer & Principal Executive Officer |
| Shannon Charles | Chief Marketing Officer |
| Zeb Booker | Chief Technology Officer |
| Bradley Whitford | Chief Accounting Officer, Treasurer & Secretary |
| David Johnson | Senior Vice President of Business Development |
| Dr. Sibyl Swift Ph.D. | CSO, Vice President of Regulatory Affairs & Director |
| Francisco Mangual | Senior Vice President of Sales |
| Lance Blundell | General Counsel |
| Robert Pettway | Director of Public Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 27, 2025 | 10-K/A | [Amend] Annual Report |
| Jan 15, 2025 | 8-K | Current Report |
| Jan 10, 2025 | 8-K | Current Report |
| Jan 03, 2025 | 8-K | Current Report |
| Dec 23, 2024 | 8-K | Current Report |
| Dec 18, 2024 | 10-K | Annual Report |
| Nov 27, 2024 | 8-K | Current Report |
| Sep 30, 2024 | 4 | Filing |
| Sep 25, 2024 | 4 | Filing |
| Aug 30, 2024 | 8-K/A | [Amend] Current Report |